Lexington Partners reached a final close on its eighth global secondaries fund at the hard cap of $10.1 billion. It is the largest dedicated secondaries vehicle ever raised.
There are more than 300 LPs in the fund, with significant commitments from leading public and corporate pension funds and sovereign wealth funds in North America, Europe, Asia Pacific, Latin America and...
India’s Innoven Capital, a joint venture between UOB and Temasek Holdings-owned Seviora Holdings, has fractionalised a USD 50m venture debt fund using blockchain and smart contracts.
OneVentures and UniQuest have led a AUD 34m (USD 23m) funding round for Vaxxas, an Australia-based biotechnology company running clinical programmes that include a needle-free COVID-19 vaccine candidate.
Temasek Holdings, A91 Partners, and Kae Capital have invested USD 135m in Indian omnichannel wellness products retailer HealthKart.